Dose-dense, dose-intense chemotherapy delivers

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Phase I Trial of Dose-Dense Docetaxel and Doxorubicin with or without Sargramostim in Patients with Metastatic Breast Cancer

By Montero Alberto   Booser Daniel   Esparza-Guerra Laura   Murray James   Rosales Marguerite   Hortobagyi Gabriel   Valero Vicente  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy in Breast Cancer

By Lake Diana E.   Hudis Clifford A.  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1851-1860

Adis International

Access to resources Recommend Favorite

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors

By Medioni Jacques   Huchon Cyrille   >  

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes

By Lyman Gary H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 99-108

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite